These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23268195)

  • 21. [Obsessive-compulsive symptoms in schizophrenia].
    Kayahan B; Oztürk O; Veznedaroğlu B
    Turk Psikiyatri Derg; 2005; 16(3):205-15. PubMed ID: 16180153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Deep brain stimulation in psychiatric disorders].
    Denys D
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2330-5. PubMed ID: 19024063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
    Poyurovsky M; Faragian S; Shabeta A; Kosov A
    Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Obsessive-compulsive disorder and schizophrenia. A critical review].
    Frommhold K
    Fortschr Neurol Psychiatr; 2006 Jan; 74(1):32-48. PubMed ID: 16429333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder.
    Denys D; Mantione M; Figee M; van den Munckhof P; Koerselman F; Westenberg H; Bosch A; Schuurman R
    Arch Gen Psychiatry; 2010 Oct; 67(10):1061-8. PubMed ID: 20921122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p11 and gene therapy for severe psychiatric disorders: a practical goal?
    Chen G; Twyman R; Manji HK
    Sci Transl Med; 2010 Oct; 2(54):54ps51. PubMed ID: 20962329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consent to deep brain stimulation for neurological and psychiatric disorders.
    Glannon W
    J Clin Ethics; 2010; 21(2):104-11. PubMed ID: 20866016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep brain stimulation in obsessive-compulsive disorder.
    Denys D; Mantione M
    Prog Brain Res; 2009; 175():419-27. PubMed ID: 19660670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment-refractory OCD from the viewpoint of obsessive-compulsive spectrum disorders: impact of comorbid child and adolescent psychiatric disorders].
    Kano Y
    Seishin Shinkeigaku Zasshi; 2013; 115(9):990-6. PubMed ID: 24228477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The decision making: neuroanatomy, functional exploration and mental disorders].
    Tomassini A; Struglia F; Stratta P; Pacifico R; Gianfelice D; Spaziani D; Rossi A
    Riv Psichiatr; 2009; 44(4):226-41. PubMed ID: 20066795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Informed consent for clinical trials of deep brain stimulation in psychiatric disease: challenges and implications for trial design.
    Lipsman N; Giacobbe P; Bernstein M; Lozano AM
    J Med Ethics; 2012 Feb; 38(2):107-11. PubMed ID: 21685148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report.
    Aouizerate B; Cuny E; Martin-Guehl C; Guehl D; Amieva H; Benazzouz A; Fabrigoule C; Allard M; Rougier A; Bioulac B; Tignol J; Burbaud P
    J Neurosurg; 2004 Oct; 101(4):682-6. PubMed ID: 15481726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obsessive compulsive disorder. Clinical and epidemiologic studies].
    Hantouche E; Lepine JP
    Encephale; 1989; 15(3):309-18. PubMed ID: 8641157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep brain stimulation of the nucleus accumbens and bed nucleus of stria terminalis for obsessive-compulsive disorder: a case series.
    Islam L; Franzini A; Messina G; Scarone S; Gambini O
    World Neurosurg; 2015 Apr; 83(4):657-63. PubMed ID: 25527882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An introduction to Kundalini yoga meditation techniques that are specific for the treatment of psychiatric disorders.
    Shannahoff-Khalsa DS
    J Altern Complement Med; 2004 Feb; 10(1):91-101. PubMed ID: 15025884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
    Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
    Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment strategies for obsessive-compulsive disorder.
    Marazziti D; Consoli G
    Expert Opin Pharmacother; 2010 Feb; 11(3):331-43. PubMed ID: 20102301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obsessive-compulsive symptoms in schizophrenia: prevalance and clinical correlates.
    Kayahan B; Ozturk O; Veznedaroglu B; Eraslan D
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):291-5. PubMed ID: 15896222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.